The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes after complete pathologic response (pCR) to neoadjuvant treatment for gastric and gastroesophageal junction (GEJ) adenocarcinoma.
Ryan C. Fields
Disclosure not yet available
Vivian E. Strong
Disclosure not yet available
Mithat Gonen
Disclosure not yet available
Murray F. Brennan
Disclosure not yet available
Daniel G. Coit
Disclosure not yet available
Manish A. Shah
Disclosure not yet available